Sponsored Webinars are brought to you on a complimentary basis on behalf of an organization. The sponsor is underwriting the costs, so we are able to offer these webinars free of charge.
Demystifying the Clinical Trial Outsourcing Landscape: How to cut through the noise and identify the right solutions for your trial
Cytometry meets biosensing – real-time binding kinetics measurements on living cells
Beyond Intent: Addressing Diversity, Inclusion, and Equitable Participation in Clinical Trials for Patients and Your Business
Automated flow cytometry staining and its broad applicability to immunological assay formats and platforms
Dawn of a new era: ctDNA-based biomarker detection for cancer diagnosis, response monitoring, and minimal residual disease
High Throughput, Low volume Product Stability and Purity Analysis for AAV and Lentiviral Gene Therapies
Introducing ClinEco: The First B2B Marketplace Connecting Clinical Trial Professionals, CROs, Providers, and Sites
A State-of-the-Art Expression Platform for Expanding the Boundaries of Standard and Complex Therapeutic Protein
Knowledge discovery reimagined: finding new hypotheses with Causaly Cloud
Assessing neuraminidase presence in influenza vaccines using InDevR’s VaxArray Platform
Bite into hands-free, on-the-money buffer exchange with Unagi and Big Tuna
Characterization and Identification of Subvisible Protein and Polysorbate Aggregates in Protein Therapeutics
How to select and validate a generic CHO HCP ELISA for process development
Cytotoxicity Bioassays – Measuring Antibody-Mediated Direct Cell Death
Analyzing multiple biomarkers with IHC: putting a 6-plex kit to the challenge
A Roadmap for Digitalization in Life Sciences: A Case Study Featuring PACT Pharma & L7 Informatics
Anti-drug Antibody Analysis for Preclinical Studies
Mass Spectrometry as a Disruptive Technology for Emerging Biotherapeutic Modalities
Comprehensive Specificity Profiling of Antibody-Based Therapeutics Using the Membrane Proteome Array
Go beyond expectations in viral vector analytics, cell and gene therapy process development and quality control
Managing Quality and Compliance Operations in an Accelerating Scientific Landscape
Upgrade your vaccine development and bioprocess optimization by replacing laborious ELISA, SRID, or TCID50
Finding the Needle in a Haystack: Rapid Assays to Detect Degraded Polysorbate and Other Problems Lurking in your Formulation
SUPPORTING YOUR SEARCH FOR NOVEL CHEMICAL EQUITY & QUALIFIED HITS
How to Choose an Automated Liquid Handler: Tips and Tricks to Help You on Your Way
Expression of a Diverse Array of Biomolecules: The SUREtechnology Modular Approach
Neutralization mechanisms of human anti-alphavirus monoclonal antibodies
ParticleSentryᴬᴵ: Combining A.I. & Flow Imaging Microscopy to Analyze and Monitor Biologics
Challenges and processes for development and scale-up of stem cell therapies
Introducing the Aura CL: Subvisible Particle Detection for Cell and Gene Therapy
Serious Synthetic Biology: Developing Codon Optimization Designs for Vaccines
De-risking Biologics: T-Cell Engager and Bispecific Fusion Protein Case Studies
Function First: Using complementary antibody platforms to fight Covid-19
Automated Reagent Preparation for Analytical, Down Stream Processing, Formulation and QC Labs
Building a Systems Biology Data Fabric
The Benefits of Sequential, Multiplexed Westerns using RePlex on Simple Western: 3 case studies from University of Lausanne
Accelerating discovery for CAR-T & other biologics: Mammalian display technology for antibody discovery & affinity maturation
Target selectivity of multispecific antibodies: practical analysis of binding kinetics and avidity
Automated Analysis of Protein Secondary Structure Change from Ligand Binding Using Microfluidic Modulation Spectroscopy
Digital Transformation in Molecular Diagnostic Labs: A Case Study with WASHU/MGI/GTAC
Characterization and formulation of therapeutic macromolecules using light scattering
Simultaneous, High-Yield Extraction of DNA and RNA from FFPE Tissue – Purigen Biosystems Ionic®
Employing a Hybrid AI Approach to Maximize Your Data Value
Serious Synthetic Biology: Engineered Cynomologous mAbs for Improved Immunogenicity Studies
How Process Raman Spectroscopy Can Assist in the Production of Biotherapeutics
Mammalian Cell-based Library Screening, TARGATT™ Rapid Site-specific Integration Technology
Considering Australia as part of your Clinical Development Pathway
Improving team working and information delivery across Design-Make-Test-Analyze: Spotlight on compound synthesis
Accelerating Life Science Discovery by Enabling Lab and Data Automation
Immunology Drug Research: Using in vitro assays to select and support in vivo efficacy studies
Advancing our understanding of neuroinflammation: Driving a systems biology approach to re-classify brain disease
Cas-CLOVER™ “the clean alternative to CRISPR-Cas9” and piggyBac® for cell line development & engineering
Cell therapy specificity screening: Assessing off-target liabilities and generating tox data for INDs
Preclinical evaluation of antimetastatic drug candidates using a next-generation chicken embryo model
Methods to Mitigate Target Interference in Anti-Drug Antibody Assays
Effective Discovery and Validation of Cancer Drug Targets Through Scalable Genome Engineering
Protein or Not? Advanced Aggregate and Particle Analysis with the Aura
Leveraging Automated High-throughput Clonal Selection: How MicroScale Purifications Prevent Bottlenecks and Increase Success
Explore AAV formulation and stability with Big Tuna and Uncle
Protein Adsorption and Aggregation in Fill-Finish Pumping Systems: Effect of Surface Charges
Digital Bioprocessing: Addressing complexity and accelerating process development through data and automation tools
Best Practices for Small to Mid-Size Companies to Advance Drug Discovery Programs
Top 5 Data Governance Strategies for Life Sciences
IBD: pre-clinical models and translating efficacy to human disease
Optimizing personalized drug dosing for patients with drug-specific Pharmacokinetic data models
Get ahead in the race with high-quality peptide discovery and binding kinetics for therapeutic and diagnostics development
Viable Cell Density and Viability in High Throughput cell culture applications
IP and R&D Trends in Biological Sequencing
The Digital Lab. “What it is and How we get there”
Accelerating Genomic Research with Hybrid Cloud Solutions
Introduction to Protein Footprinting
Next Generation Diagnostic Assay Development Fueled by Synthetic Antibody Libraries
Automated Multi-Attribute Method (MAM) Sample Preparation
Optical Sensors for Real-time pH and Dissolved Oxygen Measurements in Cell Culture: Cell Secrets Revealed
De-risking Antibody Discovery: Tips for Success from Industry Experience
Get More DNA, and now RNA, from FFPE Tissue with Half the Effort
Predicting stability of antibody therapeutics by unfolded-state studies with high-throughput dynamic light scattering
Integration of soft-sensor technologies with CHO-cell predictive models for improved bioreactor automation & process control
What is the GDPR and how to operationalize it?
Accelerating small molecule discovery chemistry by optimizing your Design-Make-Test-Analyze workflow
Remdesivir for COVID-19: Case Study and Clinical Trial Design
Improve Translation of Humanized Animal Models for Immunotherapy
On-target development - Specificity screening of biotherapeutics to avoid off-target liabilities
Analytical Validation of CTC Enumeration using the RareCyte Platform and Implementation in a Global Clinical Trial
Overcoming Irreproducibility in Life Science Research through Recombinant Antibodies, Protein Sequencing and More
Worldwide Distributed Computing Initiative Tackling COVID-19 Drug Discovery
Testing Needs for COVID-19 and Beyond
COVID-19 Serological Test Development
DRIVE™ : Brothers in Arms to support small molecule drug discovery from Hit to IND
Embracing Telehealth and Virtual Care Delivery Post COVID-19
Engineering Optimized Anti-SARS-CoV-2 Antibody Therapeutics
Getting Back to Work – Strategies to Prepare for the Reopening of Halted Clinical Trials
Neuroinflammation in Chronic Pain – A Case for Interdisciplinary Research
Clinical Trial Data Collection for Success During and After COVID-19: From Virtual Trials, EDC to DDC, BYOD, and Beyond
The Future of Supply Chain Management Post-COVID
Antibody Testing: COVID-19 Seroprevalence Studies
High Throughput Chemical Stability Screening for Proteins
Accelerating the Clinical Development Lifecycle through Digitization
Will COVID-19 Produce a New Normal in R&D -- Faster, More Decentralized, More Digitized?
How to optimize In vivo preclinical efficacy evaluation of synergistic immuno-oncology drug candidates
Process Model Evolution with Biopharm Services
Cytokine Biomarkers of Inflammatory Response in COVID-19 Patients
Workflows for biotherapeutic higher order structure characterization
Selecting best models mediated by T, B cells and innate immune system for your pre-clinical research
Laboratory Diagnosis of SARS-CoV-2: Review of Testing Methodologies
In vitro T cell exhaustion – Development and optimization of a primary immune cell assay
Fully Human Antibody Therapeutics on RenMab Discovery Platform - A Snapshot of Project Integrum
Multiplex Serological Assays for COVID-19
Gathering evidence through biochemical and biophysical characterization of biologics
Digital Infrastructure in the COVID-19 Age: Data Security, Rapid Scalability and AI for Clinical Assays and Diagnostics
Vaccine Development for COVID-19
Developing COVID-19 Diagnostics for FDA Authorization
Predicting Viral Clearance: DOE, HTS and AAV Case Studies Using a Non-Infectious MVM Surrogate in Downstream Development
Trends from the Trenches Digital
Data Ecosystems that Accelerate Scientific Research
Fast CMC Development from DNA to IND
High throughput antibody screening using next generation synthetic antibody libraries coupled with kinetic & binning assays
Overcoming limitations of ELISAs in process-related impurity testing
Catch your capsid leaks – Uncle’s tools for AAV stability and characterization
A Pharmacogenetic (PGx) Blindspot: The prevalence and Impact of CYP2D6 Hybrid Alleles
Characterization of nanotherapeutics by dynamic light scattering
Employing a Process Optimization Strategy for Improving Biopharmaceutical Assay Workflows
Cell avidity - the best predictor for clinical efficacy of T cell therapy?
Accelerating the Antibody Discovery Workflow in the Modern Therapeutic Landscape
Biosensor Development Using CRISPR to Quantify Endogenous Protein Modulated by Targeted Protein Degraders
Thermal unfolding and aggregation analysis of lead antibodies and variants derived from synthetic antibody libraries
Discover Antibody Candidates Against a Panel of Hard-to-Drug GPCR Targets: A Synthetic Antibody Library Case Study
An Automated Solution for Single-Cell Gene Expression Workflows
Integrated Drug Discovery at Jubilant Biosys: Helping Biotechs achieve differentiated outcome with our 4D approach
SPR for Aptamer-Based Molecular Interactions in Programmable Materials
Virtual screening at ultra-large scale: 1.5 billion and counting
Eurofins Integrated Cardiac Proarrythmic Risk Assessment Under The CiPA Initative
Cell-based Label-free Binding Affinity and Kinetics Using Surface Plasmon Resonance Microscopy Technology
A Gyrolab Assay for the Quantitation of Free Complement Protein C5a in Human Plasma
Warning: Which Host Cell Protein impurities is your ELISA assay missing?
Overcoming the microbiome challenge: A panel discussion
Utilization of DEPArray in molecular pathology for clinical diagnostics and translational research
Preclinical Secondary Pharmacology Is an Essential Part of Drug Discovery
Developing a toolkit towards prediction of protein aggregation
Establishing Qualified Bioassays for Checkpoint Receptors to Implement in QC Lot Release: Case Studies on PD-1 and SIRPα
Preclinical Animal Models in Cancer Supportive Care
Chemical Probes in Disease Modelling Approaches
Hereditary Cancer Risk Assessment: Benefit versus Cost within the Scope of Practicing Precision Medicine
Evolution of Contract Research Organizations to Contract Innovation and Partnership Organizations
Accurate Pharmacogenetic Characterization of Challenging Samples: Management of Low-Quality DNA and CYP2D6 Hybrid Alleles
Understanding the mechanism of NK mediated Tumor Immunity and Cytotoxicity
Harnessing the True Power of Metabolomics with the 4Cs
Seeking the Unseen: Sub-Visible Particle Analysis as a Core Analytical Technique
Conformation Change of a Monoclonal Antibody in Real Time, Mimicking Low pH Hold Viral Inactivation
AbTheneum Discovers Rare Hits and Delivers Antibody Metadata: Anti-BCMA Antibody Case Study
Why industry leaders are choosing the Simoa technology for Phase I – IV Clinical Studies
CIon channels as therapeutic antibody targets
Clinical Flow Cytometry: Validation and Implementation in a Regulatory Setting
Take charge of your Clean-in-Place (CIP) processes with Uncle
Antibody Affinity Extraction (AAE) empowers HCP identification by Mass Spectrometry
Say goodbye to manual buffer exchange with Big Tuna